Correction: TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-κB Dependent Induction of cFLIPL
Main Authors: | Josep Maria Lluis, Ulrich Nachbur, Wendy Diane Cook, Ian Edward Gentle, Donia Moujalled, Maryline Moulin, Wendy Wei-Lynn Wong, Nufail Khan, Diep Chau, Bernard Andrew Callus, James Edward Vince, John Silke, David Lawrence Vaux |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997110/?tool=EBI |
Similar Items
-
TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.
by: Josep Maria Lluis, et al.
Published: (2010-01-01) -
Correction: TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-κB Dependent Induction of cFLIPL.
by: Josep Maria Lluis, et al.
Published: (2010-01-01) -
Survival Function of the FADD-CASPASE-8-cFLIPL Complex
by: Christopher P. Dillon, et al.
Published: (2012-05-01) -
Identification and Characterization of the Interaction Site between cFLIPL and Calmodulin.
by: Gabriel Gaidos, et al.
Published: (2015-01-01) -
MIND bomb 2 prevents RIPK1 kinase activity-dependent and -independent apoptosis through ubiquitylation of cFLIPL
by: Osamu Nakabayashi, et al.
Published: (2021-01-01)